Agios Pharmaceuticals (AGIO)
(Delayed Data from NSDQ)
$48.19 USD
-1.53 (-3.08%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $48.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Agios Pharmaceuticals, Inc. [AGIO]
Reports for Purchase
Showing records 301 - 306 ( 306 total )
Company: Agios Pharmaceuticals, Inc.
Industry: Medical - Products
Lull in News Flow Till 2H15, Awaiting Better Entry Points
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: Agios Pharmaceuticals, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Agios Pharmaceuticals, Inc.
Industry: Medical - Products
4Q/FY-14 Preview, Upcoming AG-120 Data Key to Support Valuation
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: Agios Pharmaceuticals, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Agios Pharmaceuticals, Inc.
Industry: Medical - Products
Transformational Science, But Valuation Keeps Us On the Sidelines
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D